- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Duolingo stock steady as Citizens maintains Market Perform rating amid CFO change | ||
| Mo | Goldman Sachs reiterates Sell rating on Apellis stock amid revenue miss | ||
| Mo | Soleno Therapeutics stock falls despite revenue beat as patient starts decline | ||
| Mo | Alphatec stock plunges 20% despite Freedom Capital reiterating Buy rating | ||
| Mo | BridgeBio stock maintains Buy rating at TD Cowen on strong Attruby sales | ||
| Mo | Biohaven stock maintains Outperform rating at Baird on promising IgAN data | ||
| Mo | MasTec stock rating reiterated at Buy by Clear Street, citing entry point | ||
| Mo | Boot Barn stock price target raised to $195 from $180 at Jefferies | ||
| Mo | OpenText completes eDOCS divestiture to NetDocuments for $163 million | ||
| Mo | William Blair reiterates Outperform rating on argenx stock | ||
| Mo | Baird raises Rocket Lab USA price target to $100 from $83 on contract win | ||
| Mo | Innomed secures €5.5 million debt financing for catheter development | ||
| Mo | Jefferies raises Lockheed Martin stock price target to $540 on potential catalysts | ||
| Mo | Truist Securities reiterates Buy rating on Duolingo stock amid CFO transition | ||
| Mo | Swiss dental firm unveils drill-free cavity treatment at JP Morgan event | ||
| Mo | Ayvens launches €750 million bond offering with stabilization period | ||
| Mo | Biomea Fusion outlines 2026 diabetes and obesity drug development plans | ||
| Mo | E.ON SE launches €1.6 billion dual-tranche bond offering | ||
| Mo | Nomura downgrades Coupang stock to Neutral on data breach fallout | ||
| Mo | Curasight reports early positive data from brain cancer treatment trial | ||
| Mo | Planet Fitness ends 2025 with 20.8 million members, 6.7% sales growth | ||
| Mo | Precigen reports strong adoption of RRP treatment PAPZIMEOS | ||
| Mo | FDA rejects Atara's tabelecleucel application in surprise reversal | ||
| Mo | Senseonics reports 71% revenue growth in Q4, guides higher for 2026 | ||
| Mo | Mereo BioPharma updates setrusumab program, extends cash runway |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .